Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan-Reference-Cited by-同舟云学术

Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan

Published:2017-02 Issue:2 Volume:27 Page:107-114
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Saito Toshio,Kawai Mitsuru,Kimura En,Ogata Katsuhisa,Takahashi Toshiaki,Kobayashi Michio,Takada Hiroto,Kuru Satoshi,Mikata Takashi,Matsumura Tsuyoshi,Yonemoto Naohiro,Fujimura Harutoshi,Sakoda Saburo

Funder

Ministry of Health, Labour and Welfare

Ministry of Health, Labour and Welfare of Japan

NCNP

National Hospital Organization Network Joint Research

Publisher

Elsevier BV

Subject

Genetics(clinical),Clinical Neurology,Neurology,Pediatrics, Perinatology, and Child Health

Reference40 articles.

1. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management;Bushby;Lancet Neurol,2010

2. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care;Bushby;Lancet Neurol,2010

3. Current treatment of adult Duchenne muscular dystrophy;Wagner;Biochim Biophys Acta,2007

4. Database of wards for patients with muscular dystrophy in Japan;Saito,2012

5. Changes in clinical condition and causes of death of inpatients with Duchenne muscular dystrophy in Japan from 1999 to 2012;Saito;Rinsho Shinkeigaku,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self- and Caregiver-Reported Participation, Quality of Life, and Related Mood and Behavior Challenges in People Living With Dystrophinopathies;Pediatric Neurology;2024-02

2. Caregiver Burden with Duchenne and Becker Muscular Dystrophy in Japan: A Clinical Observation Study;Internal Medicine;2024-02-01

3. Evaluation of pro-regenerative and anti-inflammatory effects of isolecanoric acid in the muscle: Potential treatment of Duchenne Muscular Dystrophy;Biomedicine & Pharmacotherapy;2024-01

4. Polysymptomatology and Polypharmacy at End of Life in Patients with Duchenne Muscular Dystrophy;The Journal of Pediatrics;2023-10

5. End of Life in Boys and Young Men With Duchenne Muscular Dystrophy – The Perspective of Dying Men and Their Families: A Systematic Review and Thematic Synthesis of Qualitative Evidence;OMEGA - Journal of Death and Dying;2023-07-05